Free

New England CEPAC Meeting: Oral Semaglutide for Type 2 Diabetes

Event Information

Share this event

Date and Time

Location

Location

Stephen Robert '62 Campus Center

75 Waterman Street

Providence, RI 02912

View Map

Event description
ICER Public Meeting to Deliberate on the Comparative Clinical and Cost Effectiveness of Oral Semaglutide for Type 2 Diabetes

About this Event

The New England Comparative Effectiveness Public Advisory Council (CEPAC), a core program of the Institute for Clinical and Economic Review (ICER), will hold a public meeting on November 14, 2019 to consider the comparative clinical effectiveness and value of oral semaglutide (Novo Nordisk) for type 2 diabetes.

Approximately 29 million Americans have diabetes, of whom 95% have the type 2 form. The management of type 2 diabetes has received significant attention over the past decade due to the increasing prevalence of this condition and the rise in costs associated with its treatment.

A presentation of the evidence will be followed by a public comment period and deliberations and votes by the New England CEPAC. The votes will be followed by a policy roundtable discussion. This is ICER's second review of treatments for Type 2 Diabetes, the first of which took place in 2014.

A list of key dates for stakeholder engagement opportunities and other important information associated with the review of oral semaglutide for type 2 diabetes can be found on ICER's website at https://icer-review.org/topic/type-2-diabetes/.

The public meeting will take place in the Petteruti Lounge and Kasper Multipurpose Room of Stephen Roberts Campus Center at Brown University in Providence, Rhode Island.

Share with friends

Date and Time

Location

Stephen Robert '62 Campus Center

75 Waterman Street

Providence, RI 02912

View Map

Save This Event

Event Saved